Skip to content

Main Navigation

Clinical Study

Sofosbuvir (SOF) and Velpatasvir (VEL): Study Drugs for Pregnant Women with Hepatitis C

Hepatitis C is an infection in the liver. Sofosbuvir (SOF) and Velpatasvir (VEL) are approved drugs for people with Hepatitis C. These drugs are not approved for pregnant women with Hepatitis C. Research is needed to know the safety and effectiveness of these SOF and VEL for use in pregnant women. The information we learn may aid future patients.

I AM INTERESTED

For more information contact:

Stephanie Castro

  storc@utah.edu
  (385) 280-3885

IRB#: IRB_00152415 | PI: Marcela Smid | Department: OBSTETRICS AND GYNECOLOGY | Approval Date: 2022-08-24 06:00:00
Specialties: Gastroenterology, OB/Gyn, General

Who can participate?

 Gender: Female Only

 Age: Under 7 or over 18 years old

 Volunteers: Volunteers with special conditions

 Location: In Person


Inclusion Criteria:

  • Ages 18-45 years old
  • Pregnant with one baby
  • Hepatitis C diagnosis and infection at least 6 months before participation
  • Negative Hepatitis B test
  • In-person at the University of Utah

Exclusion Criteria:

  • Use of medication to treat Hepatitis C before participation
  • History of severe liver disease including cirrhosis

Will I be paid for my time?

Yes

Last Updated: 8/23/22